GH Research (GHRS) Research & Development (2020 - 2025)

GH Research (GHRS) recorded quarterly Research & Development of -$66.1 million in Q4 2025, down 725.93% quarter-over-quarter from $10.6 million in Q3 2025, and down 6.98% on a YoY basis from -$71.1 million in Q4 2024.

GH Research (GHRS) Research & Development (2020 - 2025) Analysis & Trends

GH Research's Research & Development history runs 6 years deep, the most recent figure standing at -$66.1 million for Q4 2025.

  • In Q4 2025, Research & Development fell 6.98% year-over-year to -$66.1 million; the TTM figure through Dec 2025 stood at -$38.8 million (down 10.71% YoY), while the FY2025 annual figure was -$38.8 million, down 10.71% from the prior year.
  • Research & Development was -$66.1 million for Q4 2025 at GH Research, down from $10.6 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $13.8 million in Q4 2021 to a low of -$66.1 million in Q4 2025.
  • Historically, Research & Development has averaged -$1.2 million across 5 years, with a median of $7.1 million in 2023.
  • Biggest YoY gain for Research & Development was 3004.97% in 2021; the steepest drop was 4547.27% in 2021.
  • A 5-year view of Research & Development shows it stood at $13.8 million in 2021, then sank by 49.76% to $6.9 million in 2022, then gained by 19.41% to $8.3 million in 2023, then sank by 849.32% to -$61.8 million in 2024, then dropped by 6.98% to -$66.1 million in 2025.
  • The last three Research & Development figures came in at -$66.1 million (Q4 2025), $10.6 million (Q3 2025), and $9.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 4.32 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 15.66 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 626,092.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -101.30 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 1.46 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -2.30 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 357,444.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 961.60 Mn
9 Abivax 94.26 Bn 94.26 Bn - -58.00 Mn
10 GH Research 9.73 Bn 9.63 Bn - -66.14 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -66.14 Mn
Sep 30, 2025 10.57 Mn
Jun 30, 2025 8.96 Mn
Mar 31, 2025 7.85 Mn
Dec 31, 2024 -61.83 Mn
Sep 30, 2024 8.40 Mn
Jun 30, 2024 9.76 Mn
Mar 31, 2024 8.66 Mn
Dec 31, 2023 8.25 Mn
Sep 30, 2023 7.09 Mn
Jun 30, 2023 7.18 Mn
Mar 31, 2023 7.31 Mn
Dec 31, 2022 6.91 Mn
Sep 30, 2022 4.62 Mn
Jun 30, 2022 4.24 Mn
Mar 31, 2022 -4.71 Mn
Dec 31, 2021 13.76 Mn
Sep 30, 2021 -2.56 Mn
Jun 30, 2021 -1.95 Mn
Mar 31, 2021 -692,000.00